Marc Renaud

Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myelome

Hervé Avet‐Loiseau, Michel Attal, Philippe Moreau et al. · Blood · 2007 · 905 citations · Full text

Medicine, Genetics, Hematology +15

Melphalan and prednisone plus thalidomide versus melphalan and prednisone alone or reduced-intensity autologous stem cell transplantation in elderly patients with multiple myeloma (IFM 99–06): a randomised trial

Thierry Façon, Jean Yves Mary, Cyrille Hulin et al. · The Lancet · 2007 · 870 citations

Medicine, Hematology, Oncology +17

Bortezomib plus dexamethasone as induction treatment prior to autologous stem cell transplantation in patients with newly diagnosed multiple myeloma: results of an IFM phase II study.

Jean‐Luc Harousseau, Michel Attal, Xavier Leleu et al. · PubMed · 2006 · 335 citations

Medicine, Pharmacology, Pharmacotherapy +15

Analysis of Risk Factors for Outcomes After Unrelated Cord Blood Transplantation in Adults With Lymphoid Malignancies: A Study by the Eurocord-Netcord and Lymphoma Working Party of the European Group for Blood and Marrow Transplantation

Celso Arrais‐Rodrigues, Guillermo Sanz, Claudio G. Brunstein et al. · Journal of Clinical Oncology · 2008 · 202 citations

Medicine, Hematology, Oncology +17

Determinants of paradoxical CD4 cell reconstitution after protease inhibitor-containing antiretroviral regimen

Marc Renaud, Christine Katlama, Alain Mallet et al. · AIDS · 1999 · 124 citations

Life Sciences, Immunology, Infectious Diseases +16